NLRP3-IN-12 is a specific inhibitor of the NLRP3 inflammasome, effectively reducing IL-1beta release by targeting the NLRP3 protein, and demonstrating an IC50 of 0.45 µM. This compound is utilized in the research of inflammatory bowel disease.
Molecular Weight:
518
Formula:
C27H32ClNO7
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted
